Skip to main navigation Skip to search Skip to main content

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed Changes

  • Jose de Leon
  • , Ross J. Baldessarini
  • , Richard Balon
  • , John Bilbily
  • , Stanley N. Caroff
  • , Leslie Citrome
  • , Christoph U. Correll
  • , Robert O. Cotes
  • , John M. Davis
  • , Lynn E. DeLisi
  • , Justin Faden
  • , Oliver Freudenreich
  • , David R. Goldsmith
  • , Ronald Gurrera
  • , Richard C. Josiassen
  • , John M. Kane
  • , Deanna L. Kelly
  • , Matcheri S. Keshavan
  • , Robert S. Laitman
  • , Y. W.Francis Lam
    • Jonathan G. Leung, Raymond C. Love, Betsy McCollum, Ian R. McGrane, Jonathan M. Meyer, Henry A. Nasrallah, Frederick C. Nucifora, Anthony J. Rothschild, Jose M. Rubio, Martha Sajatovic, Deepak K. Sarpal, Georgios Schoretsanitis, Mujeeb Shad, Charles Shelton, Leo Sher, Balwinder Singh, Sandarsh Surya, Theodore R. Zarzar, Emilio J. Sanz, Carlos De las Cuevas
  • University of Kentucky
  • University of the Basque Country
  • Harvard University
  • Wayne State University
  • Washington University St. Louis
  • VA Medical Center
  • University of Pennsylvania
  • New York Medical College
  • Northwell Health
  • Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
  • Charité – Universitätsmedizin Berlin
  • Emory University
  • University of Illinois at Chicago
  • Temple University
  • Department of Veterans Affairs
  • University of Texas Health Science Center at San Antonio
  • Mayo Clinic Rochester, MN
  • University of Maryland, Baltimore
  • University of California at San Diego
  • University of Cincinnati
  • Johns Hopkins University
  • University of Massachusetts Medical School
  • Case Western Reserve University
  • University of Pittsburgh
  • University of Zurich
  • University of Nevada, Las Vegas
  • Icahn School of Medicine at Mount Sinai
  • Augusta University
  • University of North Carolina at Chapel Hill
  • University of La Laguna
  • Hospital Universitario de Canarias

Research output: Contribution to journal › Review article › peer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed Changes'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science